These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 19726831)

  • 21. Long-term follow-up of drug-eluting stents when inserted for on- and off-label indications.
    Qasim A; Cosgrave J; Latib A; Colombo A
    Am J Cardiol; 2007 Dec; 100(11):1619-24. PubMed ID: 18036358
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute coronary syndrome is an independent risk factor for late incomplete stent apposition after sirolimus-eluting stent implantation.
    Zhang RY; DU R; Zhu ZB; Zhang Q; Hu J; Lü AK; Zhang JS; Shen WF
    Chin Med J (Engl); 2008 Dec; 121(24):2504-8. PubMed ID: 19187586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term follow-up evaluation after sirolimus-eluting stent implantation by optical coherence tomography: do uncovered struts persist?
    Takano M; Yamamoto M; Inami S; Murakami D; Seimiya K; Ohba T; Seino Y; Mizuno K
    J Am Coll Cardiol; 2008 Mar; 51(9):968-9. PubMed ID: 18308167
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical outcomes after sirolimus-eluting, paclitaxel-eluting, and bare metal stents (from the first phase of the prospective multicenter German DES.DE Registry).
    Nienaber CA; Akin I; Schneider S; Senges J; Fetsch T; Tebbe U; Willich SN; Stumpf J; Sabin GV; Silber S; Richardt G; Kuck KH;
    Am J Cardiol; 2009 Nov; 104(10):1362-9. PubMed ID: 19892051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Very late thrombosis after drug-eluting stents.
    Feres F; Costa JR; Abizaid A
    Catheter Cardiovasc Interv; 2006 Jul; 68(1):83-8. PubMed ID: 16763989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coronary aneurysm and very late stent thrombosis formation associated with sirolimus-eluting stent implantation.
    Xie HZ; Zhang SY; Zeng Y; Shen ZJ; Fang Q
    Chin Med J (Engl); 2009 Dec; 122(24):3097-8. PubMed ID: 20137510
    [No Abstract]   [Full Text] [Related]  

  • 27. Contrast staining outside the sirolimus-eluting stent leading to coronary aneurysm formation: a case of very late stent thrombosis associated with hypersensitivity reaction.
    Kon H; Sakai H; Otsubo M; Takano H; Okamoto K; Sato T; Kimura T; Inoue K
    Circ Cardiovasc Interv; 2011 Feb; 4(1):e1-3. PubMed ID: 21325194
    [No Abstract]   [Full Text] [Related]  

  • 28. Recurrent late drug-eluting stent thrombosis upon discontinuation of antiplatelet therapy.
    Varghese I; Ummer A; Roesle M; Banerjee S; Brilakis ES
    Cardiovasc Revasc Med; 2008; 9(3):179-81. PubMed ID: 18606381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Highly calcific in-stent restenosis as a substrate for sirolimus-eluting stent very late stent thrombosis.
    De Maria GL; Aurigemma C; Niccoli G
    J Cardiovasc Med (Hagerstown); 2015 Jan; 16 Suppl 1():S20-2. PubMed ID: 25062270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term (>3 Years) outcome and predictors of clinical events after insertion of sirolimus-eluting stent in one or more native coronary arteries (from the Israeli arm of the e-Cypher registry).
    Planer D; Beyar R; Almagor Y; Banai S; Guetta V; Miller H; Kornowski R; Brandes S; Krakover R; Solomon M; Lotan C
    Am J Cardiol; 2008 Apr; 101(7):953-9. PubMed ID: 18359314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Late thrombosis of paclitaxel-eluting stents: long-term incidence, clinical consequences, and risk factors in a cohort of 604 patients.
    Flores-Ríos X; Marzoa-Rivas R; Abugattás-de Torres JP; Piñón-Esteban P; Aldama-López G; Salgado-Fernández J; Calviño-Santos R; Vázquez-Rodríguez JM; Vázquez-González N; Castro-Beiras A
    Am Heart J; 2008 Apr; 155(4):648-53. PubMed ID: 18371471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term clinical outcomes and stent thrombosis of sirolimus-eluting versus bare metal stents in patients with end-stage renal disease: results of Korean multicenter angioplasty team (KOMATE) Registry.
    Kim BK; Oh S; Jeon DW; Yang JY; Kim JS; Park S; Choi D; Jang Y; Hong BK; Kwon HM; Lee SW; Goh CW; Kwon K; Ryu SK;
    J Interv Cardiol; 2009 Oct; 22(5):411-9. PubMed ID: 19702679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Temporal relation between Clopidogrel cessation and stent thrombosis after drug-eluting stent implantation.
    Roy P; Bonello L; Torguson R; Okabe T; Pinto Slottow TL; Steinberg DH; Kaneshige K; Xue Z; Satler LF; Kent KM; Suddath WO; Pichard AD; Lindsay J; Waksman R
    Am J Cardiol; 2009 Mar; 103(6):801-5. PubMed ID: 19268735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Very late thrombosis of drug-eluting stents: a brief literature review and case example.
    Agarwal SK; Shawl F; Raman VK; Binbrek AS
    J Invasive Cardiol; 2008 Dec; 20(12):655-8. PubMed ID: 19057030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sirolimus, Tacrolimus and Zotarolimus eluting stents to treat bifurcated lesions: a 7-month clinical outcome comparison.
    Brugaletta S; Burzotta F; Trani C; Todaro D; Talarico G; Porto I; Leone AM; Niccoli G; Mazzari MA; Mongiardo R; Schiavoni G; Crea F
    Minerva Cardioangiol; 2008 Feb; 56(1):35-42. PubMed ID: 18432167
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial.
    Stone GW; Midei M; Newman W; Sanz M; Hermiller JB; Williams J; Farhat N; Caputo R; Xenopoulos N; Applegate R; Gordon P; White RM; Sudhir K; Cutlip DE; Petersen JL;
    Circulation; 2009 Feb; 119(5):680-6. PubMed ID: 19171853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Late stent thrombosis of a second-generation drug- eluting stent.
    Karjalainen PP; Nammas W; Ylitalo A
    J Invasive Cardiol; 2012 Oct; 24(10):E225-7. PubMed ID: 23043049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Drug-eluting stents: long-term safety].
    Karpov IuA; Samko AN; Buza VV
    Ter Arkh; 2009; 81(5):36-41. PubMed ID: 19537584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two-year outcome of patients treated with sirolimus- versus paclitaxel-eluting stents in an unselected population with coronary artery disease (from the REWARDS Registry).
    Roy P; Bonello L; de Labriolle A; Okabe T; Pinto Slottow TL; Steinberg DH; Torguson R; Smith K; Xue Z; Satler LF; Kent KM; Suddath WO; Pichard AD; Waksman R
    Am J Cardiol; 2008 Aug; 102(3):292-7. PubMed ID: 18638589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study.
    Alfonso F; Pérez-Vizcayno MJ; Hernández R; Bethencourt A; Martí V; López-Mínguez JR; Angel J; Iñiguez A; Morís C; Cequier A; Sabaté M; Escaned J; Jiménez-Quevedo P; Bañuelos C; Suárez A; Macaya C;
    J Am Coll Cardiol; 2008 Nov; 52(20):1621-7. PubMed ID: 18992651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.